Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Rheumatoid arthritis (RA) is a chronic inflammatory disease with complex genetic factors. Single-nucleotide polymorphisms (SNPs) in the SLC22A4 gene have been previously reported to be associated with RA in Japanese but not European populations. This study further investigated the association of SLC22A4 polymorphisms, in particular slc2F1/slc2F2, with RA in the Chinese population, the largest Asian population. A total of 160 human subjects with 95 RA patients and 65 healthy controls were genotyped for slc2F1-G/A and slc2F2-C/T polymorphisms. The results showed that there was a significant difference in the genotype distribution of these two polymorphisms between the two groups. In addition, the presence of slc2F1 A allele and slc2F2 T allele carries a 1.93-fold and 2.14-fold increased risk for anticyclic citrullinated peptide (CCP) positivity, respectively. Overall, this study provided evidence that SLC22A4 gene polymorphisms played important roles in the etiology of RA in the largest Asian population, the Chinese population.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/jbt.21554 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Promising Therapeutic Targets for Intracranial Aneurysms: A Systematic druggable genome-wide Mendelian Randomization.
Cerebrovasc Dis
September 2025
Background: Intracranial aneurysm (IA), known as pathological dilation of cerebral arteries,commonly occurring at bifurcating arteries,carries a high risk of severe morbidity and mortality if left untreated.Although the treatment and early diagnosis have significantly improved,the complex pathophysiological process of IA formation presents significant challenges in the development of targeted therapies.Efficient disease-modifying therapies for IA are not yet available.
View Article and Find Full Text PDFIntegrative machine learning identifies robust inflammation-related diagnostic biomarkers and stratifies immune-heterogeneous subtypes in Kawasaki disease.
Pediatr Rheumatol Online J
June 2025
Department of Paediatricst, Youyang County People's Hospital, No. 102, Taohuayuan Avenue Middle Road, Taohuayuan Street, Youyang County, Chongqing, 409800, China.
Background: Kawasaki disease (KD), a pediatric systemic vasculitis, lacks reliable diagnostic biomarkers and exhibits immune heterogeneity, complicating clinical management. Current therapies face challenges in targeting specific immune pathways and predicting treatment responses.
Methods: Multi-cohort transcriptomic data were integrated to identify inflammation-related genes (IRGs).
The impact of inflammation and iron metabolism on gene expression alterations in ischemic stroke: a bioinformatics approach.
Sci Rep
April 2025
Department of Neurology, Zigong Fourth People's Hospital, Zigong, Sichuan, PR China.
This study explores the differential expression of inflammation and iron metabolism-related genes (IIMRDEGs) in Ischemic Stroke (IS), a major contributor to global morbidity and mortality. Using the Gene Expression Omnibus (GEO) query tool, we integrated gene expression datasets GSE22255 and GSE16561. We identified 56 differentially expressed genes (DEGs), including 42 that were upregulated and 14 downregulated, according to criteria of |logFC| > 0.
View Article and Find Full Text PDFIdentification of Novel Therapeutic Targets for Hypertension.
Hypertension
June 2025
School of Life Sciences, Beijing University of Chinese Medicine, China.
Background: Persistently high blood pressure remains the leading risk factor for mortality worldwide. This study aims to identify potential drug targets for hypertension.
Methods: Mendelian randomization was used to identify therapeutic targets for hypertension.
The impact of the solute carrier gene superfamily polymorphisms on tyrosine kinase inhibitors responses among chronic myeloid leukemia: A meta-analysis.
Leuk Res
April 2025
Falculty of Pharmaceutical Management and Economics, Hanoi University of Pharmacy, Hanoi 100000, Vietnam. Electronic address:
Background: Tyrosine kinase inhibitors (TKIs) are currently the first-line therapy for chronic myeloid leukemia (CML), but proportion of treatment responses may be influenced by genetic polymorphisms, especially, the solute carrier gene superfamily (SLC). This study was conducted to evaluate the relationship of polymorphisms in the SLC genes family and treatment responses to TKIs among CML patients.
Methods: A systematic search was conducted from four databases, including PubMed, Cochrane Library, Embase and Web of Science, up to March 2023.